Margit Dlaska
Impact in
- Hematology top 10%
- Iron Metabolism and Disorders
-
- Hemoglobinopathies and Related Disorders
Papers in
-
- DNA Repair Mechanisms 3
- RNA modifications and cancer 3
- CRISPR and Genetic Engineering 2
- Advanced biosensing and bioanalysis techniques 1
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Günter Weiß (2 shared papers)Wolfgang Hilbe (6 shared papers)Wolfgang Eisterer (5 shared papers)Oliver Bechter (5 shared papers)Josef Thaler (3 shared papers)Thomas Kühr (2 shared papers)Christian Bogdan (1 shared paper)Gernot Fritsche (1 shared paper)
- Journals
- The Journal of Immunology (3 papers)International Journal of Oncology (2 papers)Journal of Clinical Pathology (1 paper)Journal of Bacteriology (1 paper)Cell Cycle (1 paper)
- Partner nations
- AustriaSwitzerlandIndia
In The Last Decade
Margit Dlaska
16 papers receiving 533 citations
Peers
Comparison fields: 5 of 86
- Hematology 89
- Genetics 66
- Developmental Neuroscience 25
- Immunology 122
- Physiology 101
Countries citing papers authored by Margit Dlaska
This map shows the geographic impact of Margit Dlaska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margit Dlaska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margit Dlaska more than expected).
Fields of papers citing papers by Margit Dlaska
This network shows the impact of papers produced by Margit Dlaska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margit Dlaska. The network helps show where Margit Dlaska may publish in the future.
Co-authors
The 25 scholars most cited alongside Margit Dlaska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 154 | |
| 2 | 2003 | 74 | |
| 3 | 1997 | 61 | |
| 4 | 2002 | 58 | |
| 5 | 2004 | 42 | |
| 6 | 2006 | 36 | |
| 7 | 2006 | 30 | |
| 8 | 2008 | 23 | |
| 9 | 1995 | 16 | |
| 10 | 2003 | 13 | |
| 11 | Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT). | 2011 | 12 |
| 12 | 2003 | 8 | |
| 13 | 2005 | 7 | |
| 14 | 2008 | 4 | |
| 15 | 2013 | 4 | |
| 16 | 2011 | 1 |
About Margit Dlaska
Margit Dlaska is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Physiology and Immunology, having authored 16 papers that have together received 543 indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (4 papers), Lung Cancer Treatments and Mutations (3 papers), DNA Repair Mechanisms (3 papers), RNA modifications and cancer (3 papers), Colorectal Cancer Treatments and Studies (2 papers), CRISPR and Genetic Engineering (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Nerve injury and regeneration (1 paper). The work is most often cited by research in Hematology (89 citations), Genetics (66 citations), Developmental Neuroscience (25 citations), Immunology (122 citations) and Physiology (101 citations). Margit Dlaska has collaborated with scholars based in Austria, Switzerland and India. Frequent co-authors include Günter Weiß, Wolfgang Hilbe, Wolfgang Eisterer, Oliver Bechter, Josef Thaler, Thomas Kühr, Christian Bogdan, Gernot Fritsche, Katja Garimorth and Martin Röllinghoff. Their work appears in journals such as The Journal of Immunology, International Journal of Oncology, Journal of Clinical Pathology, Journal of Bacteriology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.